Health charity Scleroderma & Raynaud's UK (SRUK) is urging the public to take a 60-second online test to find out if they may ...
Following recent reports on the rise in corridor care and growing A&E waits, many are concerned by the devastating collapse ...
Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.
A vet shared a detailed video with essential items to include in your pet's first aid kit, helping you stay prepared for ...
SALT LAKE CITY, UTAH / ACCESS Newswire / February 6, 2025 / CenExel, a leading network of clinical research sites, proudly congratulates and ...
Symbravo can rapidly eliminate migraine pain within two hours, with efficacy sustained through 24 and 48 hours, across migraine pain severity ...
The first patient has been enrolled in a Phase 1 trial by the NHLBI that's evaluating fostamatinib as a treatment for sickle ...
In 2004, a research group at Peking University First Hospital discovered a mutation in the gene coding for a sodium-channel ...
Hemlibra was found to ease pain and improve quality of life for hemophilia A patients, even those with long-term joint damage ...
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
CNN wellness expert Dr. Leana Wen suggests what to do to reduce your risk of catching respiratory viruses this winter and how ...
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.